Zydus launches Ramelteon Tablets in US upon receiving approval from USFDA

July 25, 2019

Zydus Cadila announced the Day – 1 launch of Ramelteon Tablets (US RLD –Rozerem Tablets), 8 mg upon receiving the final approval from the USFDA. Ramelteon is a sedative, also called a hypnotic. It works by affecting certain substances in the body that help regulate the "sleep-wake cycle."


Ramelteon is used to treat insomnia that is associated with having trouble falling asleep. The drug will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad. The group now has 270 approvals and has so far filed over 360 ANDAs since the commencement of the filing process in FY 2003-04.


Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The group employs over 23,000 people worldwide and is dedicated to creating healthier communities globally. Zydus aspires to be a research-based pharmaceutical company by 2020

Please reload

Recent Posts

Please reload


Please reload